EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing harmaline as a novel approach to reverse tmexCD1-toprJ1-mediated tigecycline resistance against klebsiella pneumoniae infections

Jindian Yang, Lei Xu, Yonglin Zhou, Minhe Cui, Dejun Liu, Jianfeng Wang, Yang Wang, Xuming Deng

Microbial Cell Factories · 24.05.2024 · 23 (1)

DOI: 10.1186/s12934-024-02410-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Cell Factories, online erschienen am 24.05.2024. Verfasst von Jindian Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Tigecycline, Klebsiella Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Research Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A novel plasmid-mediated resistance–nodulation–division (RND) efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae tremendously threatens the use of convenient therapeutic options in the post-antibiotic era, including the “last-resort” antibiotic tigecycline.

Results

In this work, the natural alkaloid harmaline was found to potentiate tigecycline efficacy (4- to 32-fold) against tmexCD1-toprJ1- positive K. pneumoniae , which also thwarted the evolution of tigecycline resistance. Galleria mellonella and mouse infection models in vivo further revealed that harmaline is a promising candidate to reverse tigecycline resistance. Inspiringly, harmaline works synergistically with tigecycline by undermining tmexCD1-toprJ1- mediated multidrug resistance efflux pump function via interactions with TMexCD1-TOprJ1 active residues and dissipation of the proton motive force (PMF), and triggers a vicious cycle of disrupting cell membrane integrity and metabolic homeostasis imbalance.

Conclusion

These results reveal the potential of harmaline as a novel tigecycline adjuvant to combat hypervirulent K. pneumoniae infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeTigecyclineKlebsiella InfectionsAnti-Bacterial AgentsDrug RepositioningHarmalineAnimalsMiceMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialBacterial ProteinsMembrane Transport ProteinsFemale

Stichwörter der Autor:innen

Klebsiella pneumoniaetmexCD1-toprJ1HarmalineTigecycline

Substanzen

TigecyclineAnti-Bacterial AgentsHarmalineBacterial ProteinsMembrane Transport Proteins

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
  • Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, School of Life Sciences, Ningxia University, Yinchuan, China.
  • Jilin Province Mushuo Livestock Farming Co., Ltd., Jilin, China.
  • Beijing Key Laboratory of Detection Technology for Animal-Derived Food Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Beijing Key Laboratory of Detection Technology for Animal-Derived Food Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China. wangyang@cau.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Postdoctoral Research Foundation of China

Zitieren

APA

Yang, J., Xu, L., Zhou, Y., Cui, M., Liu, D., Wang, J., Wang, Y., & Deng, X. (2024). Repurposing harmaline as a novel approach to reverse tmexCD1-toprJ1-mediated tigecycline resistance against klebsiella pneumoniae infections. Microbial Cell Factories, 23(1). https://doi.org/10.1186/s12934-024-02410-4

Vancouver

Yang J, Xu L, Zhou Y, Cui M, Liu D, Wang J, et al. Repurposing harmaline as a novel approach to reverse tmexCD1-toprJ1-mediated tigecycline resistance against klebsiella pneumoniae infections. Microbial Cell Factories. 2024;23(1). doi:10.1186/s12934-024-02410-4

BibTeX
@article{Yang2024,
  author = {Yang, Jindian and Xu, Lei and Zhou, Yonglin and Cui, Minhe and Liu, Dejun and Wang, Jianfeng and Wang, Yang and Deng, Xuming},
  title = {Repurposing harmaline as a novel approach to reverse tmexCD1-toprJ1-mediated tigecycline resistance against klebsiella pneumoniae infections},
  journal = {Microbial Cell Factories},
  year = {2024},
  volume = {23},
  number = {1},
  doi = {10.1186/s12934-024-02410-4}
}
Kostenlos starten →